Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.
about
Interventions for morpheaSystemic Sclerosis and Malignancy: A Review of Current DataCurrent perspectives on the immunopathogenesis of systemic sclerosisGenetics of systemic sclerosis: recent advancesIdentification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing.A critical view on cardiovascular risk in systemic sclerosis.Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.Compensation for occupational skin diseasesCross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group StudyExercise echocardiography for the assessment of pulmonary hypertension in systemic sclerosis: a systematic review.Measuring illness behavior in patients with systemic sclerosisGlycoprofiling as a novel tool in serological assays of systemic sclerosis: a comparative study with three bioanalytical methods.Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.Antiphospholipid antibodies and systemic scleroderma.Sex-specific environmental influences on the development of autoimmune diseasesElucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry.Mechanobiological dysregulation of the epidermis and dermis in skin disorders and in degenerationTreatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesDendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis.Is there evidence for vasculitis in systemic sclerosis?The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis.An overview of environmental risk factors in systemic sclerosis.Unfolding the pathogenesis of scleroderma through genomics and epigenomics.Genetic and epigenetic abnormalities in systemic sclerosis.Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review.Scleroderma renal crisis and renal involvement in systemic sclerosis.Emerging drugs and therapeutics for systemic sclerosis.The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseasesIncidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil.Serum adipokines levels in patients with systemic sclerosis: A meta-analysis.Risk factors for malignancy in systemic sclerosis patients.Sex Differences in Pediatric Rheumatology.Understanding coping strategies among people living with scleroderma: a focus group study.A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance.Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association?
P2860
Q24194241-C71BCBA6-52C0-4605-BD28-4F1EEBD0EF94Q26740318-431ABED2-9FD7-47B9-809F-12DB983FBF0FQ26741264-609317C1-142D-4D56-88B1-53C38DD82FFFQ26796362-840459DA-B8AD-4D0C-928F-0912D371F1CEQ28397539-4E878825-96C7-47C2-882A-DA605F9E91F8Q30249024-985C3C5F-DB70-4CBB-8FEF-2954D86874FAQ33596457-94BA76A7-E531-44DF-B0B9-A549D9CF3DA4Q33857158-4741688F-552A-4E5F-BEAD-C6195EDC7469Q35743365-ACB24FD2-0020-43DA-8533-287774D10512Q35967757-A0ECC60F-D400-4DC9-B30A-9C88C8BC1353Q36066243-75DA8B94-D0C2-42CE-AEFB-A2CFCC8DE9E4Q36625804-626399AC-C97C-4D14-A5F6-3704A4206908Q36943783-7A1401B5-F16E-4DD7-B63E-31252A66A788Q37176160-5294D7C3-A92F-40DD-9E74-96168F04E4B9Q37193945-34F8A5E5-BB36-4DF5-9DB2-D4AFA86DA6B7Q37248651-ACA44DEF-8B14-4D6A-9458-9503CC9FDA98Q37282479-B9DD05CB-0BB1-4B88-9419-44F32EAB7EABQ37294709-2295A46D-EDE6-4F92-A72E-8F864EC47719Q37381549-EA8664B6-83EB-4140-8204-B8BABD2E23B6Q37395851-89F95D89-220E-4B2A-8B4A-D30BF5A1D6F9Q38052089-3B4F3597-08C0-4B86-9D5E-0978EBA76320Q38152687-DADC4167-6B0C-4026-9E41-A66E34431A50Q38156227-BF5198F6-5EB3-4C02-84FD-DE957183672CQ38366114-29361C30-5BEA-4CD1-9983-960DBDD112ADQ38648592-91A5DBC1-7283-4B4D-8627-7215A0BE71C1Q38681645-AC9B557D-DFE4-478B-95A4-5CDD38789096Q38701980-7A082334-3C28-4A2B-B40E-EF2DC3E31BCEQ38869606-7DB5DBCC-F5DC-45C0-BEFA-BD6AA4BF5583Q38957950-AF447753-EFDC-4F67-998C-EB14B2D389E2Q38998611-BFF522AC-3FFB-4458-9916-79D54F3F350DQ39211384-CA16450E-5493-42FE-BADD-77140DC653E2Q39332233-DEA2A72D-AF7C-48BC-A744-0B9955A4F760Q39671627-1F164E5F-B027-4575-A55D-5343FBDBFCC7Q39818936-547F3239-E2CA-4B9A-83E1-7F13FC704919Q40041622-88754AD6-D074-450F-88A1-5AE974EE572EQ40079518-64C611FA-6959-402C-8E8D-4068B3C9BAD0Q40230825-A655EF53-FF2A-494A-80FD-6CB25D2E84A7Q41223874-BA08DC95-EFC4-43FD-B115-114717D5BBD9Q41641441-30A602F9-0E50-4764-9813-015CC804558BQ41651775-7C8C6BB7-3631-42BE-AF85-139EF0742061
P2860
Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Epidemiology of systemic scler ...... y, and environmental triggers.
@ast
Epidemiology of systemic scler ...... y, and environmental triggers.
@en
Epidemiology of systemic scler ...... y, and environmental triggers.
@nl
type
label
Epidemiology of systemic scler ...... y, and environmental triggers.
@ast
Epidemiology of systemic scler ...... y, and environmental triggers.
@en
Epidemiology of systemic scler ...... y, and environmental triggers.
@nl
prefLabel
Epidemiology of systemic scler ...... y, and environmental triggers.
@ast
Epidemiology of systemic scler ...... y, and environmental triggers.
@en
Epidemiology of systemic scler ...... y, and environmental triggers.
@nl
P1476
Epidemiology of systemic scler ...... y, and environmental triggers.
@en
P2093
Jammie Barnes
Maureen D Mayes
P304
P356
10.1097/BOR.0B013E32834FF2E8
P577
2012-03-01T00:00:00Z